Medical News

Daily news and information for physicians in a range of specialties and practice settings.

Latest Medical News

Oral Molecule Trial Shows Promise in MS Relapse Reduction
The multi-dosage longterm studies of Cladribine Tablets were shared at CMSC.
Alemtuzumab Improves RRMS Activity Over 6 Years, Study Says
The study was a continuation of a 2-year alemtuzumab study versus interferon.
HCV Reinfection Uncommon Among Patients on Opioid Substitution Therapy After DAA Treatment, Study Suggests
Direct-acting antiviral medication impacts HCV infection in patients on opioid substitution therapy.
Dysfunctional Breathing Associated with Poor Asthma Control in Patients
Dysfunctional breathing had strong connections to poor asthma control.
Management of Acute Myocardial Infarction Reviewed
A review of Initial presentation and management of acute myocardial infarction.
Modified Patient Education Programs Do Not Improve Asthma Control
Patient education programs show no noticeable effect on actual asthma control.
The Impact of Low-Dose Levosimendan for Hemodynamic Support After Cardiac Surgery
Study results also showed that levosimendan did not positively affect secondary outcome measures compared to placebo.

Product News

Rheumatoid Arthritis Treatment Wins FDA Approval
Rheumatoid Arthritis Treatment Wins FDA Approval
Sarilumab would be able to treat adult patients with moderately-to-severely active rheumatoid arthritis who cannot tolerate one or more disease modifying antirheumatic drugs like methotrexate.
First Drug to Specifically Treat Giant Cell Arteritis Gains FDA Approval
This is the first FDA-approved therapy specific to this form of vasculitis.
FDA Approves New ALS Drug For First Time in Two Decades
Edavarone becomes first drug approved for disease since 1995.
Pfizer Seeks to Expand Tofacitinib Approval to Include Psoriatic Arthritis
FDA to consider Xeljanz, the sole JAK inhibitor available in US, for new indication.
FDA Approves Infliximab Biosimilar
Infliximab-abda approved for range of gastroenterological and rheumatoid conditions.
Amgen Takes Aim at Sanofi and Regeneron Blockbuster Dupilumab
Already at war over PCSK9, drug giants go to court over another breakthrough drug.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$